Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Fangzhou Information Technology Co., Ltd. is a subsidiary of Fangzhou Inc. (HKEX: 06086), operating as a leading digital health and online chronic disease management platform in China under the brand Fangzhou Jianke (方舟健客). The company provides comprehensive internet healthcare services through its H2H (Hospital-to-Home) Smart Healthcare Ecosystem, which integrates online consultation, health management, and pharmaceutical e-commerce. Leveraging advanced AI technologies, including its proprietary XingShi Large Language Model and DeepSeek integrations, the platform connects millions of registered users with hundreds of thousands of physicians. Its services focus on improving the accessibility and efficiency of long-term care and precision medicine solutions for chronic disease patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Fangzhou Information Technology.